Np mrd loader

Record Information
Version2.0
Created at2024-08-12 04:29:38 UTC
Updated at2024-09-23 16:35:13 UTC
NP-MRD IDNP0333725
Natural Product DOIhttps://doi.org/10.57994/3204
Secondary Accession NumbersNone
Natural Product Identification
Common NameAlbusamide G
Description It was first documented in 2024 (PMID: 39313750). Based on a literature review a significant number of articles have been published on Albusamide G (PMID: 39313711) (PMID: 39313682) (PMID: 39313676) (PMID: 39313672).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC14H29NO2
Average Mass243.3910 Da
Monoisotopic Mass243.21983 Da
IUPAC NameN-[(11R)-11-hydroxydodecyl]acetamide
Traditional NameN-[(11R)-11-hydroxydodecyl]acetamide
CAS Registry NumberNot Available
SMILES
C[C@@H](O)CCCCCCCCCCNC(C)=O
InChI Identifier
InChI=1S/C14H29NO2/c1-13(16)11-9-7-5-3-4-6-8-10-12-15-14(2)17/h13,16H,3-12H2,1-2H3,(H,15,17)/t13-/m1/s1
InChI KeyOQQZVYKILXPIKN-CYBMUJFWSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
COSY NMR[1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
HSQC NMR[1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR1H NMR Spectrum (1D, 600.31470692, CD3OD, simulated)sy643@kiost.ac.krKorea Institute of Ocean Science and TechnologyJung2024-08-12View Spectrum
Species
Species of Origin
Species NameSourceReference
Albus
      Not Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.61ChemAxon
pKa (Strongest Acidic)16.45ChemAxon
pKa (Strongest Basic)-1.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area49.33 ŲChemAxon
Rotatable Bond Count11ChemAxon
Refractivity71.79 m³·mol⁻¹ChemAxon
Polarizability31.4 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Chen Z, Li X, Xu G, Xiao T, Wang D, Wang C, Zhang K, Li J, Pan Y, Qiao Y, Zhang Y: Synergize Strong and Reactive Metal-Support Interactions to Construct Sub-2 nm Metal Phosphide Cluster for Enhanced Selective Hydrogenation Activities. Angew Chem Int Ed Engl. 2024 Sep 23:e202413788. doi: 10.1002/anie.202413788. [PubMed:39313750 ]
  2. Syben A, Weber S, Appelmann I, Rolke R: [N-Check: nerve check to document chemotherapy-induced peripheral neuropathy (CIPN) in incurable cancer]. Schmerz. 2024 Sep 23. doi: 10.1007/s00482-024-00828-8. [PubMed:39313711 ]
  3. Mills ES, Wang JC, Richardson MK, Chung BC, Mayer LW, Gallo MC, Alluri RK, Hah RJ, Heckmann ND: The change in lumbar lordosis from the standing to the lateral position: implications for lateral interbody fusion. Eur Spine J. 2024 Sep 23. doi: 10.1007/s00586-024-08493-2. [PubMed:39313682 ]
  4. Ball BH, Peper P, Bugg JM: When is context used to guide prospective memory monitoring? Psychon Bull Rev. 2024 Sep 23. doi: 10.3758/s13423-024-02568-3. [PubMed:39313676 ]
  5. Xiao C, Xu R, Luo Y, Xu Z, Tang C: Is second (131)I treatment necessary for differentiated thyroid cancer patients and who could not benefit from it? A real-world retrospective study in China. Ann Nucl Med. 2024 Sep 23. doi: 10.1007/s12149-024-01984-8. [PubMed:39313672 ]